Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
COVID-19 meds like Paxlovid will soon have big price tags
Oct 30, 2023
The pills still will be available at no cost until those bought earlier by the federal government run out.
FDA allows Florida to import cheaper drugs from Canada
Jan 05, 2024
The plan would let Florida buy selected drugs in bulk from Canada, following FDA review.
Antibiotics not helpful for cough due to lower respiratory tract infection
Apr 25, 2024
Despite patient beliefs, no effect was seen on the severity or duration of the cough.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Nurse practitioners no more likely than doctors to prescribe inappropriately
Oct 23, 2023
Nurse practitioners were overrepresented among clinicians with the highest and lowest rates of inappropriate prescribing.
Inflation Reduction Act estimated to yield billions in drug savings
Feb 02, 2023
The ceiling prices for negotiation would have reduced Medicare prescription drug spending by ~5% if implemented from 2018 to 2020.
Pfizer restarts production plant in North Carolina following tornado damage in July
Sep 26, 2023
Most of the damage happened at the plant’s storage facility rather than its medication production areas.